Clinical trials
Observational Migraine Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 10 |
| 2024 | 13 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
| Recruiting | 16 |
| Terminated | 4 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Enrolling by invitation | 2 |
| Suspended | 2 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Theranica | 11 |
| Pfizer | 6 |
| AbbVie | 4 |
| Thomas Jefferson University | 4 |
| University of California, San Francisco | 3 |
| Children's Hospital Medical Center, Cincinnati | 2 |
| Georgetown University | 2 |
| Mayo Clinic | 2 |
| National Institute of Mental Health (NIMH) | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Migraine Disorders | 80 |
| Headache | 17 |
| Anxiety Disorders | 5 |
| Epilepsy | 5 |
| Headache Disorders | 5 |
| Fibromyalgia | 4 |
| Irritable Bowel Syndrome | 4 |
| Alzheimer Disease | 3 |
| Autistic Disorder | 3 |
| Bipolar Disorder | 3 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.